EQUITY Equity (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Foreign Currency Items |
|
Total |
|
(in thousands) |
| Balance at December 31, 2022 |
$ |
41,283 |
|
|
$ |
(131,359) |
|
|
$ |
(90,076) |
|
Other comprehensive income before reclassifications |
14,002 |
|
|
100,752 |
|
|
114,754 |
|
| Amount reclassified from AOCI |
(12,436) |
|
|
— |
|
|
(12,436) |
|
| Net other comprehensive income |
1,566 |
|
|
100,752 |
|
|
102,318 |
|
| Balance at September 30, 2023 |
$ |
42,849 |
|
|
$ |
(30,607) |
|
|
$ |
12,242 |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
| Weighted average common shares—basic |
228,787,263 |
|
|
225,761,777 |
|
|
228,497,712 |
|
|
224,123,130 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
2,371,755 |
|
|
6,060,991 |
|
|
2,252,391 |
|
|
7,409,515 |
|
| Convertible senior notes |
13,004,660 |
|
|
11,864,035 |
|
|
4,396,292 |
|
|
8,085,275 |
|
| Weighted average common shares—diluted |
244,163,678 |
|
|
243,686,803 |
|
|
235,146,395 |
|
|
239,617,920 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Options to purchase shares of common stock |
3,750 |
|
|
3,750 |
|
|
3,750 |
|
|
3,750 |
|
| Restricted stock and deferred stock—unvested |
2,361,832 |
|
|
1,340,319 |
|
|
2,430,242 |
|
|
1,260,701 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
— |
|
|
— |
|
|
8,921,749 |
|
|
3,778,760 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
2,365,582 |
|
|
1,344,069 |
|
|
11,355,741 |
|
|
5,043,211 |
|
|